This statistic shows the probability of phase III success for new drugs in the U.S., in the period from January 1, 2011, to November 30, 2020, by disease area. It was found that drugs in hematology had the highest phase III success rates.
The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020
Only company-sponsored, FDA registration-enabling development
programs were included in this analysis. Investigator-sponsored studies and combinations with other
investigational drugs were excluded.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization, & Pharma Intelligence, & QLS Advisors. (February 26, 2021). The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020 [Graph]. In Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/
Biotechnology Innovation Organization, und Pharma Intelligence, und QLS Advisors. "The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020." Chart. February 26, 2021. Statista. Accessed November 18, 2024. https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/
Biotechnology Innovation Organization, Pharma Intelligence, QLS Advisors. (2021). The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020. Statista. Statista Inc.. Accessed: November 18, 2024. https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/
Biotechnology Innovation Organization, and Pharma Intelligence, and QLS Advisors. "The Probability of Phase Iii Success for New Drugs in Select Disease Areas in The U.S. between 2011 and 2020." Statista, Statista Inc., 26 Feb 2021, https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/
Biotechnology Innovation Organization & Pharma Intelligence & QLS Advisors, The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020 Statista, https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/ (last visited November 18, 2024)
The probability of phase III success for new drugs in select disease areas in the U.S. between 2011 and 2020 [Graph], Biotechnology Innovation Organization, & Pharma Intelligence, & QLS Advisors, February 26, 2021. [Online]. Available: https://www.statista.com/statistics/597742/drug-development-phase-three-probability-of-success/
